Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Respironics to be Covered by MMP™ Portfolio License

Thank you. The USPTO doesn't validate based on number or quality of press releases. Geez.

Futher, Respironics isn't really a new license. It is the extension of an existing agreement. Phillips had already purchased a license. This just covers their acquisition of Respironics. I'd guess that this add-on license is for peanuts.



Share
New Message
Please login to post a reply